DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Olfactory transduction	R-HSA-9751605	map04740	flecainide	3356	drug-path
Adipocytokine signaling pathway	R-HSA-168638	map04920	flecainide	3356	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	flecainide	3356	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	flecainide	3356	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	flecainide	3356	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	flecainide	3356	drug-path
ABC transporters	R-HSA-1369007	map02010	flecainide	3356	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	eucatropine	7534	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	eucatropine	7534	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	eucatropine	7534	drug-path
Asthma	R-HSA-444620	map05310	eucatropine	7534	drug-path
Allograft rejection	R-HSA-9679028	map05330	eucatropine	7534	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	eucatropine	7534	drug-path
Olfactory transduction	R-HSA-9751605	map04740	eucatropine	7534	drug-path
Parkinson's disease	R-HSA-1643685	0	eucatropine	7534	drug-path
Pathways in cancer	R-HSA-9824443	map05200	difenidol	10621	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	difenidol	10621	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	difenidol	10621	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	difenidol	10621	drug-path
Amyotrophic lateral sclerosis (ALS)	Q8NDH6-2	0	difenidol	10621	drug-path